Annual total expenses:
$202.10M+$53.17M(+35.70%)Summary
- As of today (September 18, 2025), CLDX annual total expenses is $202.10 million, with the most recent change of +$53.17 million (+35.70%) on December 31, 2024.
- During the last 3 years, CLDX annual total expenses has risen by +$128.30 million (+173.85%).
- CLDX annual total expenses is now at all-time high.
Performance
CLDX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$57.33M+$2.84M(+5.21%)Summary
- As of today (September 18, 2025), CLDX quarterly total expenses is $57.33 million, with the most recent change of +$2.84 million (+5.21%) on June 1, 2025.
- Over the past year, CLDX quarterly total expenses has increased by +$18.99 million (+49.53%).
- CLDX quarterly total expenses is now -53.09% below its all-time high of $122.20 million, reached on March 31, 2018.
Performance
CLDX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CLDX Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.7% | +49.5% |
| 3 y3 years | +173.8% | +58.5% |
| 5 y5 years | +247.9% | +408.8% |
CLDX Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +173.8% | at high | +110.8% |
| 5 y | 5-year | at high | +254.6% | at high | +408.8% |
| alltime | all time | at high | >+9999.0% | -53.1% | >+9999.0% |
CLDX Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $57.33M(+5.2%) |
| Mar 2025 | - | $54.49M(+12.9%) |
| Dec 2024 | $202.10M(+35.7%) | $48.27M(+6.5%) |
| Sep 2024 | - | $45.31M(+18.2%) |
| Jun 2024 | - | $38.34M(+16.3%) |
| Mar 2024 | - | $32.96M(-30.5%) |
| Dec 2023 | $148.93M(+36.1%) | $47.44M(+19.3%) |
| Sep 2023 | - | $39.78M(+29.3%) |
| Jun 2023 | - | $30.77M(+1.5%) |
| Mar 2023 | - | $30.33M(+7.9%) |
| Dec 2022 | $109.45M(+48.3%) | $28.10M(+3.3%) |
| Sep 2022 | - | $27.19M(-24.8%) |
| Jun 2022 | - | $36.17M(+55.7%) |
| Mar 2022 | - | $23.22M(+13.4%) |
| Dec 2021 | $73.80M(+29.5%) | $20.48M(-0.6%) |
| Sep 2021 | - | $20.61M(+22.3%) |
| Jun 2021 | - | $16.85M(-2.1%) |
| Mar 2021 | - | $17.22M(-32.9%) |
| Dec 2020 | $56.99M(-1.9%) | $25.68M(+72.5%) |
| Sep 2020 | - | $14.89M(+32.2%) |
| Jun 2020 | - | $11.27M(-26.6%) |
| Mar 2020 | - | $15.35M(+35.5%) |
| Dec 2019 | $58.10M(-32.4%) | $11.33M(-5.2%) |
| Sep 2019 | - | $11.96M(-4.3%) |
| Jun 2019 | - | $12.49M(-33.1%) |
| Mar 2019 | - | $18.66M(+67.2%) |
| Dec 2018 | $85.94M(-29.6%) | $11.17M(+36.4%) |
| Sep 2018 | - | $8.18M(-57.3%) |
| Jun 2018 | - | $19.17M(-84.3%) |
| Mar 2018 | - | $122.20M(+1574.7%) |
| Dec 2017 | $122.07M(-12.6%) | $7.30M(-75.9%) |
| Sep 2017 | - | $30.29M(-6.5%) |
| Jun 2017 | - | $32.40M(-9.5%) |
| Mar 2017 | - | $35.80M(+4.7%) |
| Dec 2016 | $139.70M(+3.5%) | $34.18M(+7.4%) |
| Sep 2016 | - | $31.82M(-4.6%) |
| Jun 2016 | - | $33.34M(-7.3%) |
| Mar 2016 | - | $35.98M(+4.4%) |
| Dec 2015 | $135.02M(+7.1%) | $34.48M(+4.5%) |
| Sep 2015 | - | $33.01M(-4.4%) |
| Jun 2015 | - | $34.54M(+12.6%) |
| Mar 2015 | - | $30.66M(-7.9%) |
| Dec 2014 | $126.02M(+47.3%) | $33.30M(+14.1%) |
| Sep 2014 | - | $29.18M(+1.1%) |
| Jun 2014 | - | $28.87M(-4.8%) |
| Mar 2014 | - | $30.32M(+33.7%) |
| Dec 2013 | $85.55M(+23.5%) | $22.68M(-6.0%) |
| Sep 2013 | - | $24.12M(+26.2%) |
| Jun 2013 | - | $19.11M(-3.2%) |
| Mar 2013 | - | $19.75M(-3.5%) |
| Dec 2012 | $69.28M(+31.5%) | $20.45M(+12.8%) |
| Sep 2012 | - | $18.14M(+14.9%) |
| Jun 2012 | - | $15.78M(-1.0%) |
| Mar 2012 | - | $15.95M(+5.2%) |
| Dec 2011 | $52.66M(-1.1%) | $15.17M(+7.3%) |
| Sep 2011 | - | $14.13M(+16.0%) |
| Jun 2011 | - | $12.19M(-3.1%) |
| Mar 2011 | - | $12.57M(-16.5%) |
| Dec 2010 | $53.25M(+1.2%) | $15.06M(+31.0%) |
| Sep 2010 | - | $11.49M(-7.9%) |
| Jun 2010 | - | $12.48M(+21.2%) |
| Mar 2010 | - | $10.29M(-43.4%) |
| Dec 2009 | $52.63M(+27.0%) | $18.20M(+62.5%) |
| Sep 2009 | - | $11.20M(-1.6%) |
| Jun 2009 | - | $11.39M(-0.4%) |
| Mar 2009 | - | $11.44M(+9.5%) |
| Dec 2008 | $41.46M(+145.1%) | $10.44M(+4.3%) |
| Sep 2008 | - | $10.01M(-18.1%) |
| Jun 2008 | - | $12.22M(-45.1%) |
| Mar 2008 | - | $22.28M(+49.8%) |
| Dec 2007 | $16.91M(-14.1%) | $14.87M(+243.8%) |
| Sep 2007 | - | $4.33M(+28.6%) |
| Jun 2007 | - | $3.36M(-19.4%) |
| Mar 2007 | - | $4.18M(-36.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $19.69M(-10.3%) | $6.59M(+12.5%) |
| Sep 2006 | - | $5.86M(-5.1%) |
| Jun 2006 | - | $6.18M(-7.5%) |
| Mar 2006 | - | $6.68M(+44.7%) |
| Dec 2005 | $21.95M(+7.4%) | $4.61M(-13.9%) |
| Sep 2005 | - | $5.36M(-0.2%) |
| Jun 2005 | - | $5.37M(-8.0%) |
| Mar 2005 | - | $5.84M(-4.4%) |
| Dec 2004 | $20.44M(+24.9%) | $6.11M(+44.5%) |
| Sep 2004 | - | $4.22M(-11.8%) |
| Jun 2004 | - | $4.79M(-3.0%) |
| Mar 2004 | - | $4.94M(+33.9%) |
| Dec 2003 | $16.37M(-22.6%) | $3.69M(-10.7%) |
| Sep 2003 | - | $4.13M(-3.1%) |
| Jun 2003 | - | $4.26M(+5.4%) |
| Mar 2003 | - | $4.04M(-5.6%) |
| Dec 2002 | $21.14M(-24.3%) | $4.29M(-11.4%) |
| Sep 2002 | - | $4.84M(-16.7%) |
| Jun 2002 | - | $5.81M(+3.6%) |
| Mar 2002 | - | $5.60M(-28.1%) |
| Dec 2001 | $27.91M(+72.2%) | $7.79M(+12.1%) |
| Sep 2001 | - | $6.95M(+7.1%) |
| Jun 2001 | - | $6.49M(+33.4%) |
| Mar 2001 | - | $4.86M(-64.8%) |
| Dec 2000 | $16.20M(+20.7%) | $13.80M(+264.2%) |
| Sep 2000 | - | $3.79M(+31.6%) |
| Jun 2000 | - | $2.88M(+26.4%) |
| Mar 2000 | - | $2.28M(>+9900.0%) |
| Dec 1999 | $13.43M(+32.9%) | $0.00(-100.0%) |
| Sep 1999 | - | $2.85M(-11.1%) |
| Jun 1999 | - | $3.20M(+4.0%) |
| Mar 1999 | - | $3.08M(-9.0%) |
| Dec 1998 | $10.10M(+13.5%) | $3.38M(-92.8%) |
| Sep 1998 | - | $47.18M(+2829.7%) |
| Jun 1998 | - | $1.61M(-9.3%) |
| Mar 1998 | - | $1.78M(-15.4%) |
| Dec 1997 | $8.90M(-31.0%) | $2.10M(-4.5%) |
| Sep 1997 | - | $2.20M(-15.4%) |
| Jun 1997 | - | $2.60M(+23.8%) |
| Mar 1997 | - | $2.10M(-30.0%) |
| Dec 1996 | $12.90M(-18.4%) | $3.00M(+25.0%) |
| Sep 1996 | - | $2.40M(-47.8%) |
| Jun 1996 | - | $4.60M(+64.3%) |
| Mar 1996 | - | $2.80M(-31.7%) |
| Dec 1995 | $15.80M(-4.2%) | $4.10M(0.0%) |
| Sep 1995 | - | $4.10M(+7.9%) |
| Jun 1995 | - | $3.80M(-2.6%) |
| Mar 1995 | - | $3.90M(+21.9%) |
| Dec 1994 | $16.50M(-10.3%) | $3.20M(-20.0%) |
| Sep 1994 | - | $4.00M(-16.7%) |
| Jun 1994 | - | $4.80M(+4.3%) |
| Mar 1994 | - | $4.60M(-2.1%) |
| Dec 1993 | $18.40M(+62.8%) | $4.70M(-6.0%) |
| Sep 1993 | - | $5.00M(+8.7%) |
| Jun 1993 | - | $4.60M(+4.5%) |
| Mar 1993 | - | $4.40M(+2.3%) |
| Dec 1992 | $11.30M(-26.6%) | - |
| Oct 1992 | - | $4.30M(+10.3%) |
| Jul 1992 | - | $3.90M(-9.3%) |
| Apr 1992 | - | $4.30M(+10.3%) |
| Apr 1992 | $15.40M(+5.5%) | - |
| Jan 1992 | - | $3.90M(+2.6%) |
| Oct 1991 | - | $3.80M(+11.8%) |
| Jul 1991 | - | $3.40M(-10.5%) |
| Apr 1991 | $14.60M(+14.1%) | $3.80M(+5.6%) |
| Jan 1991 | - | $3.60M(0.0%) |
| Oct 1990 | - | $3.60M(-2.7%) |
| Jul 1990 | - | $3.70M(+12.1%) |
| Apr 1990 | $12.80M(+36.2%) | $3.30M(-10.8%) |
| Jan 1990 | - | $3.70M |
| Apr 1989 | $9.40M(+42.4%) | - |
| Apr 1988 | $6.60M(+73.7%) | - |
| Apr 1987 | $3.80M(+90.0%) | - |
| Apr 1986 | $2.00M | - |
FAQ
- What is Celldex Therapeutics, Inc. annual total expenses?
- What is the all time high annual total expenses for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual total expenses year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly total expenses year-on-year change?
What is Celldex Therapeutics, Inc. annual total expenses?
The current annual total expenses of CLDX is $202.10M
What is the all time high annual total expenses for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual total expenses is $202.10M
What is Celldex Therapeutics, Inc. annual total expenses year-on-year change?
Over the past year, CLDX annual total expenses has changed by +$53.17M (+35.70%)
What is Celldex Therapeutics, Inc. quarterly total expenses?
The current quarterly total expenses of CLDX is $57.33M
What is the all time high quarterly total expenses for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly total expenses is $122.20M
What is Celldex Therapeutics, Inc. quarterly total expenses year-on-year change?
Over the past year, CLDX quarterly total expenses has changed by +$18.99M (+49.53%)